Filing Details
- Accession Number:
- 0000950170-25-085755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-12 20:41:14
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-12
- Accepted Time:
- 2025-06-12 20:41:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1879013 | William Guyer | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Development Officer | No | No | No | No |
Transaction Summary
| Sold: | 20,000 shares | Avg. Price: $72.42 | Total Value: $1,448,474.57 |
| Number of Shares After Transactions: | 5,487 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-10 | 20,000 | $21.65 | 25,487 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-10 | 16,918 | $72.36 | 8,569 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-10 | 3,082 | $72.75 | 5,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2025-06-10 | 20,000 | $0.00 | 20,000 | $21.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 390,000 | 2031-09-01 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $71.70 to $72.695 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.70 to $72.97 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Fully exercisable.
Billionaire Hedge Funds
